SPRY 250516 17.50C(SPRY250516C17500) Stock Price Today

0.20
-0.25-55.56%

15min DelayTrading Apr 28 11:36 ET

0.20High0.15Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Benjamin Franklin 76

Mar 18 04:20

Upcoming Earnings!

$ARS Pharmaceuticals (SPRY.US)$
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is a biopharmaceutical company focused on developing and commercializing neffy, a needle-free intranasal epinephrine spray designed for emergency treatment of Type I allergic reactions, including anaphylaxis. Below is an analysis of SPRY stock based on available data as of March 17, 2025:
### Company Overview
- Product: Neffy is the first FDA-approved needle-free epinephrine delivery system, offering an al...

Jaguar8

Mar 6 09:01

🟡Watchlist, MARCH 6,2025, Thursday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If y...

Trytosaveabit

Mar 6 05:11

news

$ARS Pharmaceuticals (SPRY.US)$ Reuters
just
ARS Pharmaceuticals Announces FDA Approval of Neffy® 1 Mg (Epinephrine Nasal Spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to

This_Guy

Dec 20, 2024 06:31

$ARS Pharmaceuticals (SPRY.US)$
ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies
Positive
First FDA-approved needle-free epinephrine nasal spray
Rapid inclusion on Express Scripts Commercial National Formularies (9 weeks post-launch)
Access to millions of commercially insured patients
Superior product features: 30-month shelf-life, high temperature tolerance (122°F)
Negative
to patients weighing ≥30 kg (66 lbs.)
Current...

Green Dragon 2024

Nov 12, 2024 00:40

Additional info…

$ARS Pharmaceuticals (SPRY.US)$ comments from ALK CEO and sales projection. 🍾

SPRY250516C17500

News

Comments